Cisplatin plus etoposide in advanced non-small cell lung cancer patients age of 70 years or older.
Kanat
Ozkan
O
Evrensel
Turkkan
T
Demiray
Mutlu
M
Kurt
Ender
E
Gonullu
Guzin
G
Arslan
Murat
M
Manavoglu
Osman
O
Ozkan
Atilla
A
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000556:secondary; D002945:Cisplatin / Q000008:administration & dosage* / Q000009:adverse effects; D004334:Drug Administration Schedule; D005047:Etoposide / Q000008:administration & dosage* / Q000009:adverse effects; D005240:Feasibility Studies; D005260:Female; D006299:Health Services for the Aged; D006801:Humans; D007262:Infusions, Intravenous; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D016896:Treatment Outcome
D005047:Etoposide; D002945:Cisplatin